Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05551780 · ClinicalTrials.gov registry record · NA
Treatment of Calcific Total Occlusions in Peripheral Artery Disease
A NA study of Chronic Total Occlusion of Artery of the Extremities, sponsored by SoundBite Medical Solutions.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 5
- Study locations
NCT05551780: Recruiting NA study of Chronic Total Occlusion of Artery of the Extremities, sponsored by SoundBite Medical Solutions.
NCT05551780 is a NA study of Chronic Total Occlusion of Artery of the Extremities that is actively recruiting participants, run by SoundBite Medical Solutions. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05551780, a NA study of Chronic Total Occlusion of Artery of the Extremities, is actively recruiting participants, sponsored by SoundBite Medical Solutions.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 5
- Study locations
Study Summary
Prospective, multi-center, non-randomized, open label, clinical study intended to provide data to demonstrate safety and performance of the SoundBite Crossing System XS Peripheral.
Conditions Studied
Interventions
- DEVICE SoundBite Crossing System
Study Locations (5)
Other
- Medizinische Universität Graz - Graz
- Angiology Clinic and Vascular Centre - Arnsberg
Florida
- Palm Vascular Centers - Fort Lauderdale
North Carolina
- UNC REX Hospial - Raleigh
Rhode Island
- Lifespan - The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2024-12 |
| Phase | NA |
What NCT05551780 shows while recruiting
NCT05551780 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Chronic Total Occlusion of Artery of the Extremities appearing as the primary indexed condition, and to 1 intervention - of which SoundBite Crossing System is the first listed.
NCT05551780 lists 5 locations in 4 states (Other, Florida, North Carolina).
Frequently Asked Questions
What is clinical trial NCT05551780 about?
NCT05551780 is a clinical study titled "Treatment of Calcific Total Occlusions in Peripheral Artery Disease". Prospective, multi-center, non-randomized, open label, clinical study intended to provide data to demonstrate safety and performance of the SoundBite Crossing System XS Peripheral.
What is the current status of trial NCT05551780?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2023-02-21. Estimated completion is 2024-12.
What conditions does trial NCT05551780 study?
This clinical trial studies the following conditions: Chronic Total Occlusion of Artery of the Extremities.
What interventions are being tested in trial NCT05551780?
The interventions under investigation include: SoundBite Crossing System (DEVICE).
Who is sponsoring clinical trial NCT05551780?
This trial is sponsored by SoundBite Medical Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05551780 being conducted?
This trial has 5 study locations across Florida, North Carolina, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Total Occlusion of Artery of the Extremities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05551780's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,258 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI